Association between increased peripheral blood CD86-positive plasmacytoid dendritic cells and immune-related adverse events in patients with non-small cell lung cancer

MLA

Masato, Karayama, et al. “Association between Increased Peripheral Blood CD86-Positive Plasmacytoid Dendritic Cells and Immune-Related Adverse Events in Patients with Non-Small Cell Lung Cancer.” Global Health & Medicine, vol. 4, Dec. 2022, pp. 301–08. EBSCOhost, https://doi.org/10.35772/ghm.2022.01052.

APA

Masato, K., Yukihiro, M., Yusuke, I., Hironao, H., Yuzo, S., Kazuki, F., Tomoyuki, F., Noriyuki, E., Yutaro, N., Naoki, I., Takafumi, S., Shigehisa, K., Kazunori, A., & Yasuhide, Y. (2022). Association between increased peripheral blood CD86-positive plasmacytoid dendritic cells and immune-related adverse events in patients with non-small cell lung cancer. Global Health & Medicine, 4, 301–308. https://doi.org/10.35772/ghm.2022.01052

Chicago

Masato, Karayama, Mizoguchi Yukihiro, Inoue Yusuke, Hozumi Hironao, Suzuki Yuzo, Furuhashi Kazuki, Fujisawa Tomoyuki, et al. 2022. “Association between Increased Peripheral Blood CD86-Positive Plasmacytoid Dendritic Cells and Immune-Related Adverse Events in Patients with Non-Small Cell Lung Cancer.” Global Health & Medicine 4 (December): 301–8. doi:10.35772/ghm.2022.01052.